Cookies

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.


Durham Research Online
You are in:

Molecular nanomachines can destroy tissue or kill multicellular eukaryotes.

Gunasekera, Richard S. and Galbadage, Thushara and Ayala-Orozco, Ciceron and Liu, Dongdong and García-López, Victor and Troutman, Brian E. and Tour, Josiah J. and Pal, Robert and Krishnan, Sunil and Cirillo, Jeffrey D. and Tour, James M. (2020) 'Molecular nanomachines can destroy tissue or kill multicellular eukaryotes.', ACS applied materials & interfaces., 12 (12). pp. 13657-13670.

Abstract

Light-activated molecular nanomachines (MNMs) can be used to drill holes into prokaryotic (bacterial) cell walls and the membrane of eukaryotic cells, including mammalian cancer cells, by their fast rotational movement, leading to cell death. We examined how these MNMs function in multicellular organisms and investigated their use for treatment and eradication of specific diseases by causing damage to certain tissues and small organisms. Three model eukaryotic species, Caenorhabditis elegans, Daphnia pulex, and Mus musculus (mouse), were evaluated. These organisms were exposed to light-activated fast-rotating MNMs and their physiological and pathological changes were studied in detail. Slow rotating MNMs were used to control for the effects of rotation rate. We demonstrate that fast-rotating MNMs caused depigmentation and 70% mortality in C. elegans while reducing the movement as well as heart rate and causing tissue damage in Daphnia. Topically applied light-activated MNMs on mouse skin caused ulceration and microlesions in the epithelial tissue, allowing MNMs to localize into deeper epidermal tissue. Overall, this study shows that the nanomechanical action of light-activated MNMs is effective against multicellular organisms, disrupting cell membranes and damaging tissue in vivo. Customized MNMs that target specific tissues for therapy combined with spatial and temporal control could have broad clinical applications in a variety of benign and malignant disease states including treatment of cancer, parasites, bacteria, and diseased tissues.

Item Type:Article
Full text:(VoR) Version of Record
Available under License - Creative Commons Attribution Non-commercial.
Download PDF
(3659Kb)
Status:Peer-reviewed
Publisher Web site:https://doi.org/10.1021/acsami.9b22595
Publisher statement:This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
Date accepted:24 February 2020
Date deposited:11 April 2020
Date of first online publication:24 February 2020
Date first made open access:11 April 2020

Save or Share this output

Export:
Export
Look up in GoogleScholar